These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 707525)

  • 1. Response to pyridoxine hydrochloride in refractory anemia due to myelofibrosis.
    Rojer RA; Mulder NH; Nieweg HO
    Am J Med; 1978 Oct; 65(4):655-60. PubMed ID: 707525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine-responsive anemia: influence of tryptophan on pyridoxine responsiveness.
    Horrigan DL
    Blood; 1973 Aug; 42(2):187-93. PubMed ID: 4793110
    [No Abstract]   [Full Text] [Related]  

  • 3. Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Cervantes F; Hernández-Boluda JC; Alvarez A; Nadal E; Montserrat E
    Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of a case of osteomyelofibrosis which had started in infancy].
    Maas B; Ruhrmann G
    Monatsschr Kinderheilkd (1902); 1971 Jan; 119(1):56-60. PubMed ID: 5547114
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitamin B(6) therapy does not improve hematocrit in hemodialysis patients supplemented with iron and erythropoietin.
    Weissgarten J; Modai D; Oz D; Chen Levy Z; Cohn M; Marcus O; Dishi V; Galperin E; Averbukh Z
    Nephron; 2001 Apr; 87(4):328-32. PubMed ID: 11287776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only.
    Brubaker LH; Brière J; Laszlo J; Kraut E; Landaw SA; Peterson P; Goldberg J; Donovan P
    Arch Intern Med; 1982 Aug; 142(8):1533-7. PubMed ID: 7103635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of prednisone treatment for the anemia of myelofibrosis.
    Hernández-Boluda JC; Martínez-Trillos A; García-Gutiérrez V; Ferrer-Marín F; Xicoy B; Alvarez-Larrán A; Kerguelen A; Barba P; Gómez M; Herrera JC; Correa JG; Cervantes F
    Leuk Lymphoma; 2016; 57(1):120-4. PubMed ID: 25944376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia.
    Cervantes F; Alvarez-Larrán A; Hernández-Boluda JC; Sureda A; Granell M; Vallansot R; Besses C; Montserrat E
    Br J Haematol; 2006 Jul; 134(2):184-6. PubMed ID: 16740139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin for the treatment of anaemia in patients with chronic idiopathic myelofibrosis.
    Tsiara SN; Chaidos A; Bourantas LK; Kapsali HD; Bourantas KL
    Acta Haematol; 2007; 117(3):156-61. PubMed ID: 17159338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin treatment of idiopathic myelofibrosis.
    Aloe Spiriti M; Latagliata R; Avvisati G; Battistel V; Montefusco E; Spadea A; Petti MC
    Haematologica; 1993; 78(6):371-3. PubMed ID: 8175031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
    Cervantes F; Isola IM; Alvarez-Larrán A; Hernández-Boluda JC; Correa JG; Pereira A
    Ann Hematol; 2015 Nov; 94(11):1791-6. PubMed ID: 26122869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyridoxine requirements of channel catfish.
    Andrews JW; Murai T
    J Nutr; 1979 Apr; 109(4):533-7. PubMed ID: 430257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of low-dose thalidomide and prednisone combined with or without danazol for the treatment of primary myelofibrosis-associated anemia].
    Xu J; Xu Z; Qin T; Li B; Fang L; Zhang H; Hu N; Pan L; Qu S; Zhang Y; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):698-702. PubMed ID: 25152115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxymetholone treatment in myelofibrosis.
    Hast R; Engstedt L; Jameson S; Killander A; Lundh B; Reizenstein P; Skårberg KO; Udén AM; Wadman B
    Blut; 1978 Jul; 37(1):19-26. PubMed ID: 667366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EXPERIMENTAL PRODUCTION OF PYRIDOXINE DEFICIENCY ANEMIA IN RATS.
    SHEN SC; WONG PY; OGURO M
    Blood; 1964 May; 23():679-87. PubMed ID: 14142506
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
    Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
    N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.
    Rao DS; Shih MS; Mohini R
    N Engl J Med; 1993 Jan; 328(3):171-5. PubMed ID: 8417383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.
    Tefferi A; Hudgens S; Mesa R; Gale RP; Verstovsek S; Passamonti F; Cervantes F; Rivera C; Tencer T; Khan ZM
    Clin Ther; 2014 Apr; 36(4):560-6. PubMed ID: 24636526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study.
    Crosby L; Palarski VA; Cottington E; Cmolik B
    Heart Lung; 1994; 23(6):493-9. PubMed ID: 7852064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.